P PERSONALIS INC
| Market Cap | $688.48M |
| P/E Ratio | — |
| Forward P/E | -7.05 |
| Dividend Yield | — |
| Beta | 2.21 |
| 52W Range | $3.00 - $11.25 |
| # Hedge Funds | 1 |
| Sector | Healthcare |
| Industry | Diagnostics & Research |
Hedge Fund Ownership
| Investor 1 | % of Portfolio Weight of this stock in the investor's portfolio | Value Total dollar value of the position | Shares Number of shares held | Activity Portfolio change type: New, Increased, Decreased, or Sold |
|---|---|---|---|---|
| Polen Capital Management Polen Capital Management | 0.00% | $403.00K | 50,705 | Buy |
Insider Trading
| Insider Name of the company insider who made the trade 17 | Type Purchase (buy) or Sale (sell) | Shares Number of shares traded | Price Price per share at time of transaction | Value Total dollar value of the transaction | Trade Date Date the transaction was executed | Filing Date Date the SEC filing was submitted |
|---|---|---|---|---|---|---|
| Tachibana AaronCFO AND COO | Sale | 1,201 | $11.50 | $13.81K | 22 Jan 2026 | 23 Jan 2026 |
| Tempus AI, Inc. | Buy | 28,000 | $8.93 | $250.04K | 22 Dec 2025 | 13 Feb 2026 |
| Tempus AI, Inc. | Buy | 29,641 | $8.39 | $248.69K | 19 Dec 2025 | 13 Feb 2026 |
| Tempus AI, Inc. | Buy | 31,430 | $7.91 | $248.61K | 18 Dec 2025 | 13 Feb 2026 |
| Tempus AI, Inc. | Buy | 31,650 | $7.86 | $248.77K | 17 Dec 2025 | 13 Feb 2026 |
| Tempus AI, Inc. | Buy | 13,888 | $11.00 | $152.77K | 25 Nov 2025 | 13 Feb 2026 |
| Tempus AI, Inc. | Buy | 9,712 | $10.08 | $97.90K | 25 Nov 2025 | 13 Feb 2026 |
| Tachibana AaronCFO AND COO | Sale | 103,668 | $10.78 | $1.12M | 25 Nov 2025 | 28 Nov 2025 |
| Aaron TachibanaCFO AND COO | Sale | 103,668 | $10.78 | $1.12M | 25 Nov 2025 | 28 Nov 2025 |
| Tempus AI, Inc. | Buy | 25,225 | $9.87 | $248.97K | 24 Nov 2025 | 13 Feb 2026 |
| Tempus AI, Inc. | Buy | 16,599 | $9.74 | $161.67K | 21 Nov 2025 | 13 Feb 2026 |
| Tempus AI, Inc. | Buy | 9,900 | $8.84 | $87.52K | 21 Nov 2025 | 13 Feb 2026 |
| Tempus AI, Inc. | Buy | 28,827 | $8.63 | $248.78K | 20 Nov 2025 | 13 Feb 2026 |
| Tempus AI, Inc. | Buy | 30,645 | $8.12 | $248.84K | 19 Nov 2025 | 13 Feb 2026 |
| Tempus AI, Inc. | Buy | 64,750 | $7.67 | $496.63K | 18 Nov 2025 | 13 Feb 2026 |
| Hall Christopher MPRESIDENT AND CEO | Sale | 29,612 | $8.99 | $266.21K | 03 Nov 2025 | 05 Nov 2025 |
| Christopher M HallPRESIDENT AND CEO | Sale | 29,612 | $8.99 | $266.21K | 03 Nov 2025 | 05 Nov 2025 |
Frequently Asked Questions
What is PSNL stock price today?
PERSONALIS INC (PSNL) is currently trading at $6.58. The stock has a 52-week range of $3.00 to $11.25 and a market capitalization of $688.48M.
Is PSNL a good stock to buy in 2026?
PERSONALIS INC has a P/E ratio of N/A (forward P/E: N/A), a dividend yield of none, and 1-year performance of +99.4%. 1 hedge funds hold this stock. Review the fundamentals and ownership data above to make an informed decision.
Are insiders buying or selling PSNL stock?
There have been 17 insider transactions for PSNL in recent months. Insider buys can signal management confidence, while sales may reflect diversification or personal financial planning. Check the Insider Trading section above for details.
How has PSNL stock performed over the past year?
PERSONALIS INC (PSNL) has returned +99.4% over the past 12 months. The stock traded between $3.00 and $11.25 during this period, and is currently at $6.58.
Which hedge funds own PSNL (PERSONALIS INC)?
1 tracked hedge funds currently hold PSNL in their portfolios as of the latest 13F filings. See the ownership table above for the complete list.
What is PSNL's market cap and valuation?
PERSONALIS INC (PSNL) has a market capitalization of $688.48M. The trailing P/E ratio is N/A and forward P/E is N/A. The stock is classified in the Healthcare sector.
What is PSNL's revenue and profitability?
PERSONALIS INC reported revenue of $69.65M with net income of N/A and a profit margin of N/A. The stock has a beta of 2.21.
What sector is PSNL in and who are its biggest institutional holders?
PERSONALIS INC (PSNL) operates in the Healthcare sector. It is held by 1 tracked hedge funds. See the ownership table above for the complete list.